What is Ibogaine?

Ibogaine is a psychoactive compound derived from the root bark of the African shrub Tabernanthe iboga. It has been used for centuries in spiritual rituals by the Bwiti people of West Africa.

How Ibogaine Works

Ibogaine acts on multiple neurotransmitter systems in the brain, including:

NMDA receptors - Affected similarly to ketamine
Serotonin receptors - Producing antidepressant effects
Dopamine pathways - Reducing cravings for opioids and other substances
Mu-opioid receptors - Alleviating withdrawal symptoms

The Ibogaine Experience

A typical ibogaine treatment experience lasts 24-36 hours. Patients often report:

Visionary experiences and introspective journeys
Memories of past experiences surfacing
Physical sensations of the body being "reset"
Reduced withdrawal symptoms from opioids
Decreased cravings for substances

Medical Uses

Ibogaine has been studied for its potential use in treating:

Opioid addiction and dependence
Alcohol use disorder
Cocaine and methamphetamine addiction
Post-traumatic stress disorder (PTSD)
Traumatic brain injury (TBI)

Important Safety Information

⚠️ Medical Warning

Ibogaine is not approved by the FDA or any major regulatory body for medical treatment. It carries significant risks, including:

Cardiac complications (QT prolongation, arrhythmias)
Seizures
Respiratory depression
Psychological distress
In rare cases, death

Anyone considering ibogaine treatment should:

Undergo thorough medical screening
Work with experienced medical professionals
Ensure proper cardiac monitoring
Have emergency medical support available

Research and Clinical Trials

Recent developments have increased interest in ibogaine research:

2026: President Trump signed an executive order directing federal agencies to accelerate research on psychedelic compounds including ibogaine
Clinical trials are underway in various countries
Multiple academic institutions are studying ibogaine's mechanisms of action
Mexico and Brazil have seen growth in treatment centers